Earnings Data
Report Date
Jul 27, 2026Before Open (Confirmed)
Period Ending
2026 (Q2)Consensus EPS Forecast
0.29Last Year’s EPS
0.26Same Quarter Last Year
Based on 5 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The call presented strong core operating results: record quarterly net income, robust C&I loan growth, improving efficiency and solid deposit metrics. Credit trends were constructive with lower charge-offs, reduced NPAs and stable ACL coverage. However, management flagged isolated increases in classified loans, continued runoff in legacy mortgage and CRE portfolios, a competitive deposit environment, and limited near-term NIM upside. Management maintained prior guidance and emphasized disciplined organic growth and capital management rather than near-term M&A.Company Guidance
Record Net Income and Strong Earnings Growth
Net income of $51 million for Q1 2026, a company record, driving >16% year-over-year net income growth. GAAP EPS was $0.34 and adjusted EPS $0.35, up from $0.31 and $0.33 in the prior quarter.
Robust C&I Loan Growth
Average commercial & industrial (C&I) loans increased by $191 million in the quarter, representing 7.8% quarter-over-quarter growth and 28.2% year-over-year growth, supporting continued commercial momentum.
Revenue and Net Interest Income Expansion
Total revenue of $175.1 million (+12.1% year-over-year). Net interest income improved 11.5% year-over-year and grew $0.3 million (0.2%) quarter-over-quarter. Net interest margin increased to 370 basis points.
Improved Operating Leverage and Efficiency
Achieved positive operating leverage of 560 basis points quarter-over-quarter. Efficiency ratio improved to 59.4% and adjusted efficiency ratio improved to 57.8% (170 basis points improvement QoQ) with full realization of acquisition expense benefits.
Strong Capital and Shareholder Returns
Returned more than half of profits to shareholders via a $0.20 quarterly dividend (126th consecutive quarterly cash dividend). Board approved refreshed share buyback authorization up to $50 million as an additional capital management tool.
Solid Credit Metrics and Lower Charge-offs
Annualized net charge-off ratio of 16 basis points for the quarter (below the low end of full-year guidance). ACL coverage remained at 1.15%. Nonperforming assets and 90+-day delinquencies declined (90+ day delinquency down from 51 bps to 34 bps QoQ). NPAs decreased by $16.5 million to ~70 bps of average loans.
Deposit Franchise Strength
Average total deposits grew by $276 million quarter-over-quarter. Cost of deposits decreased 5 basis points to 1.48%; deposit base is granular with >719,000 accounts, average balance >$19,500 and average tenure >12 years.
Loan Growth and Balance Sheet Positioning
Average loans grew $102 million QoQ; period-end loans increased $49 million to $13.1 billion. Securities portfolio yield increased to 3.15% (+4 bps QoQ) with tactical purchases to position liquidity.
Pre-tax, Pre-provision Revenue Improvement
Pre-tax, pre-provision net revenue rose to $71.7 million, +1.5% QoQ and +9.3% YoY (adjusted), reflecting revenue growth and expense discipline.
Progress in Strategic Verticals and Branch Expansion
Nationwide commercial verticals now represent ~23% of the commercial lending portfolio. Continued investment in new financial centers (five in Columbus market under development) and emphasis on SBA, wealth, and fee businesses.
DE:NHS Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
DE:NHS Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Apr 27, 2026 | €11.04 | €11.33 | +2.68% |
Jan 26, 2026 | €9.70 | €10.29 | +6.00% |
Oct 27, 2025 | €10.30 | €9.82 | -4.63% |
Jul 29, 2025 | €10.12 | €9.84 | -2.78% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Northwest Bancshares (DE:NHS) report earnings?
Northwest Bancshares (DE:NHS) is schdueled to report earning on Jul 27, 2026, Before Open (Confirmed).
What is Northwest Bancshares (DE:NHS) earnings time?
Northwest Bancshares (DE:NHS) earnings time is at Jul 27, 2026, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of Northwest Bancshares stock?
The P/E ratio of Northwest Bancshares is N/A.
What is DE:NHS EPS forecast?
DE:NHS EPS forecast for the fiscal quarter 2026 (Q2) is 0.29.